Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
22.19
+0.47 (2.16%)
Jul 17, 2025, 2:45 PM CST
-25.66%
Market Cap9.20B
Revenue (ttm)1.12B
Net Income (ttm)179.42M
Shares Out413.66M
EPS (ttm)0.43
PE Ratio51.27
Forward PE15.27
Dividend0.15 (0.69%)
Ex-Dividend DateJun 18, 2025
Volume3,738,126
Average Volume2,322,764
Open21.73
Previous Close21.72
Day's Range21.69 - 22.24
52-Week Range20.19 - 36.05
Beta0.02
RSI61.19
Earnings DateAug 30, 2025

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,241
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

In 2024, SHA:688276's revenue was 1.23 billion, a decrease of -32.64% compared to the previous year's 1.82 billion. Earnings were 232.09 million, a decrease of -53.67%.

Financial Statements

News

There is no news available yet.